IGF2BP2 and neoplasm: To investigate the roles of IGF2BP2 in crizotinib-resistant NSCLC tumor growth, sh-IGF2BP2 was transfected into H1299/R cells to knockdown IGF2BP2, and sh-NC was used as the negative control for sh- IGF2BP2.